HUTCHMED (China) Ltd Files 6-K with Financial Data
Ticker: HMDCF · Form: 6-K · Filed: Jul 31, 2024 · CIK: 1648257
Sentiment: neutral
Topics: financial-reporting, sec-filing, foreign-issuer
TL;DR
HUTCHMED (China) Ltd dropped its Q2 2024 financials in a 6-K filing.
AI Summary
HUTCHMED (China) Ltd filed a 6-K report for the period ending June 30, 2024. The filing includes financial data such as retained earnings, additional paid-in capital, and accumulated other comprehensive income for various periods, including June 30, 2024, December 31, 2023, and June 30, 2023. The company is listed under the Pharmaceutical Preparations SIC code.
Why It Matters
This filing provides investors with updated financial statements, allowing them to assess the company's financial health and performance over the reported periods.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) that provides standard financial data without announcing major corporate events or significant changes.
Key Numbers
- 2024-06-30 — Reporting Period End Date (Indicates the end of the financial reporting period covered by the filing.)
- 2024-07-31 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- HUTCHMED (China) Ltd (company) — Filer of the 6-K report
- 20240630 (date) — End of reporting period
- 20240731 (date) — Filing date
- 0001648257 (company) — Central Index Key for HUTCHMED (China) Ltd
FAQ
What is the primary purpose of a 6-K filing?
A 6-K filing is submitted by foreign private issuers to report information that is made or is required to be made public in their home country, filed with or distributed to their securities holders, or required to be filed with a stock exchange on which the securities are traded.
What specific financial periods are covered by the data in this filing?
The filing includes data for the period ending June 30, 2024, and comparative data for December 31, 2023, and June 30, 2023.
What is HUTCHMED (China) Ltd's SIC code?
HUTCHMED (China) Ltd's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
When was HUTCHMED (China) Ltd formerly known as Hutchison China MediTech Ltd?
The company changed its name from Hutchison China MediTech Ltd to HUTCHMED (China) Ltd on July 16, 2015.
What is the business address of HUTCHMED (China) Ltd?
The business address is 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Filing Stats: 180 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-07-31 07:13:18
Filing Documents
- hcm-20240731x6k.htm (6-K) — 202KB
- hcm-20240731xex99d1.htm (EX-99.1) — 2782KB
- hcm-20240731xex99d2.htm (EX-99.2) — 307KB
- hcm-20240731xex99d1001.jpg (GRAPHIC) — 6KB
- 0001410578-24-001128.txt ( ) — 12999KB
- hcm-20240731.xsd (EX-101.SCH) — 85KB
- hcm-20240731_cal.xml (EX-101.CAL) — 84KB
- hcm-20240731_def.xml (EX-101.DEF) — 310KB
- hcm-20240731_lab.xml (EX-101.LAB) — 603KB
- hcm-20240731_pre.xml (EX-101.PRE) — 482KB
- hcm-20240731x6k_htm.xml (XML) — 2835KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant ' s name into English) 48th Floor, Cheung Kong Center , 2 Queen ' s Road Central , Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to unaudited financial results as of and for the six months ended June 30, 2024 Exhibit 99.2 HUTCHMED (China) Limited supplemental disclosures SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ JOHNNY CHENG Name: Johnny Cheng Title: Chief Financial Officer Date: July 31, 2024